Women's Health Initiative Memory Study - Epidemiology of Cognitive Health Outcomes
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Conjugated estrogens (Primary) ; Conjugated estrogens/medroxyprogesterone (Primary)
- Indications Alzheimer's disease; Dyspareunia; Menopausal syndrome; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms WHIMS-ECHO
- 07 Mar 2017 Planned End Date changed from 1 May 2016 to 1 Nov 2021.
- 07 Mar 2017 Planned primary completion date changed from 1 May 2016 to 1 Nov 2021.
- 04 Dec 2015 New trial record